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Background: This study was designed to assess the prevalence of chronic kidney disease (CKD) and associated risk
factors among the Chinese population in Taian, China.
Methods: A primary care-based cross-sectional study was conducted in Taian, China, from September to December
2012. Participants selected by a multi-stage stratified cluster sampling procedure were interviewed and tested for
hematuria, albuminuria, estimated glomerular filtration rate (eGFR) and other clinical indices. Factors associated with
CKD were analyzed by univariate and multivariate logistic regression analysis.
Results: A total of 14,399 subjects were enrolled in this study. The rates of hematuria, albuminuria and reduced eGFR
were 4.20%, 5.25% and 1.89%, respectively. Approximately 9.49% (95% CI: 8.93%–10.85%) of the participants had at least
one indicator of CKD, with an awareness of 1.4%. Univariate analyses showed that greater age, body mass index, and
systolic and diastolic blood pressure; higher levels of serum creatinine, uric acid, fasting blood glucose, triglycerides,
total cholesterol and low-density lipoprotein cholesterol; and lower eGFR were associated with CKD (p < 0.05 each).
Multivariate analysis showed that age, female gender, educational level, smoking habits, systolic blood pressure, and
history of diabetes mellitus, hyperlipidemia, hypercholesterolemia and hyperuricemia were independent risk factors
for CKD.
Conclusions: The prevalence of CKD in the primary care population of Taian, China, is high, although awareness is
quite low. Health education and policies to prevent CKD are urgently needed among this population.
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Chronic kidney disease (CKD), as defined and classified by
the Kidney Disease Outcomes Quality Initiative (K/DOQI)
of the National Kidney Foundation (NFK) [1], is one of
the most important chronic diseases worldwide [2,3].
Up to 14% of adults in the United States aged > 18 years,
representing an estimated 31.4 million people, were found
to have some degree of CKD in 2007–2010 [4]. In
Australia, CKD was common present in approximately 1
in 7 persons aged ≥ 25 years [5]. In addition to being com-
mon in developed nations, CKD is also highly prevalent in
developing countries [6]. A cross-sectional study indicated* Correspondence: xuely2539@163.com
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unless otherwise stated.that the nationwide prevalence of CKD in China was
10.8% (95% confidence interval [CI], 10.2–11.3), affecting
an estimated 119.5 million (95% CI, 112.9–125.0 million)
patients, similar to the level observed in the United States
in 2003 [7,8]. For the major outcomes of CKD are pro-
gression to kidney failure, end-stage renal disease (ESRD),
complications of decreased kidney function, and cardio-
vascular disease, CKD can greatly affect the general popu-
lation, especially individuals at high-risk for hypertension
or diabetes [9-13]. Furthermore, the rapid increase in
the prevalence of risk factors, such as diabetes, hyper-
tension, and obesity, has increased the burden of CKD,
making CKD an important socioeconomic and public
health problem [6,14].
CKD is considered to be a multi-factorial disease, with
genetic and environmental factors contributing to itsis is an Open Access article distributed under the terms of the Creative
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prevalence of CKD including gender, occupation, educa-
tion, marital status, diabetes, hypertension, hyperurice-
mia, history of kidney stones, and the use of traditional
medicines [16,17]. To better prevent and control this
disease, several studies in China have investigated the
characteristics and potential risk factors of CKD [18-20].
However, little is known about the epidemiology of
CKD in Taian, China. This study was therefore designed
to evaluate the epidemiology of CKD among a pri-




This cross-sectional survey was conducted between
September and December 2012. A multi-stage stratified
cluster sampling procedure was employed to select a
representative sample of the primary care population in
Taian, China. Briefly, two tertiary hospitals (Affiliated
Hospital of Taishan University and Taian Central Hospital)
and two secondary hospitals (Second Chinese Medicine
Hospital in Taian and Taian Rongjun Hospital) were
randomly chosen based on the population distribution
in Taian. Eighty primary care units from each hospital, or
a total of 320 units, were randomly selected; half of the
units were located in the Taishan District and half in the
Daiyue District. Subsequently, 50 subjects, aged ≥ 18 years
and living in Taian > 6 months, were randomly enrolled
from each of the 320 units. All participants provided
written informed consent, and the study protocol was
approved by the Ethics Committee of Affiliated Hospital
of Taishan University.
Questionnaire
A structured questionnaire was designed for data col-
lection. Factors analyzed included sociodemographic
status (name, age, gender, ethnicity, educational level,
marital status, financial situation and contact infor-
mation), health-related behaviors (smoking, alcohol drink-
ing, oil intake, diet, spending on food and type of
insurance), awareness of CKD and personal and family
history of relevant diseases (hypertension, diabetes melli-
tus, chronic kidney disease, hyperlipidemia and other
diseases). All participants were personally interviewed
by well-trained interviewers using uniform and standard-
ized language.
Anthropometric measurements
Standard protocols and techniques were utilized by med-
ical staff to measure anthropometric parameters, including
weight, height, systolic blood pressure (SBP), and diastolic
blood pressure (DBP). Body mass index (BMI) was calcu-
lated as weight (Kg)/height (m2).Blood and urine sample collection
Morning urine samples (non-menstrual period for women)
were obtained after an overnight fast (at least 10 h). Urin-
ary factors were measured using a Urine Analyzer (Urit
Group, China) and urinary sediments were examined by
light microscopy (Olympus Corporation, Japan). Venous
blood samples were collected at the same time and used to
measure various biomarkers, including fasting blood glu-
cose (FBG), total cholesterol (TCH), triglyceride (TG),
high density lipoprotein-cholesterol (HDL-C), low density
lipoprotein-cholesterol (LDL-C), uric acid (UA) and serum
creatinine (Scr) concentrations. All assays were performed
by well-trained laboratory technicians using reagents from
BioSino Bio-technology and Science Inc, China. Differ-
ences between males and females and between subjects
with and without CKD were analyzed.
Definitions of variables
CKD was defined as kidney damage, ascertained by the
presence of albuminuria and/or hematuria, or estimated
glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2,
irrespective of cause [21-23]. Albuminuria was defined
as urinary albumin concentration > 20 mg/L, measured
immunoturbidimetrically [7]. Subjects with hematuria
of ≥ 1+ were confirmed by microscopic analysis, with
three or more red blood cells in urinary sediments con-
sidered abnormal [21]. Scr was measured with Jaffe’s
kinetic method and eGFR was calculated by the Modifi-
cation of Diet in Renal Disease (MDRD), modified for
Chinese subjects; i.e., eGFR (mL/min/1.73 m2) = 175 ×
(Scr) − 1.234 × (age) − 0.179 × (0.742 if female) [24].
Awareness of CKD was defined as subject knowledge
of having CKD, based on a previous diagnosis by a phys-
ician. Hypertension was defined as SBP ≥ 140 mmHg
and/or DBP ≥ 90 mmHg, any use of antihypertensive
medication, or self-reported history of hypertension. Obes-
ity was defined as BMI ≥ 28 kg/m2. Diabetes mellitus was
defined as fasting blood glucose (FBG) ≥ 7.0 mmol/L
and/or postprandial blood glucose (PBG) ≥ 11.1 mmol/L,
or a history of diabetes. Hyperlipidemia (HLP) was de-
fined as TG ≥ 1.70 mmol/L and/or TCG ≥ 5.72 mmol/L,
or a history of HLP. Hyperuricemia was defined as
UA ≥ 420 μmol/L for males and ≥ 360 μmol/L for females,
or a history of hyperuricemia.
Statistical analysis
All statistical analyses were performed using SPSS 15.0
software. Categorical variables were presented as percent-
ages and compared using Pearson chi-square tests, and
continuous variables were reported as mean ± standard
deviation (SD) and compared using unpaired t-tests or
one-way analysis of variance. Multivariate logistic regres-
sion was performed to identify independent factors
associated with PKD, including age, gender, smoking,
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tions and hypertension, diabetes, cardiovascular disease,
hyperlipidemia, hyperuricemia, and other diseases. Odds
ratios (ORs) and corresponding 95% CIs were calculated.
A p-value < 0.05 was considered statistically significant.
Results
Participant characteristics
After excluding 1,601 subjects who lacked sufficient
data, 14,399 (90.0%) participants were included in this
analysis; of these, 59.46% were males and 40.54% were
females. Baseline demographic, anthropometric and la-
boratory data are shown in Table 1. The mean age of all
subjects was 48.97 ± 17.02 years (range, 18–89 years),
while the mean ages of males and females were 49.64 ±
16.65 and 48.13 ± 18.01 years, respectively. Age, BMI,
SBP, DBP, Scr, UA, FBG, TG, and eGFR were signifi-
cantly higher in males (p < 0.05 each), whereas HDL-C
and LDL-C were significantly higher in female (p < 0.05
each). TCH was similar in males and females (p > 0.05).
Prevalence of CKD
Of the 14,399 subjects, 1,366 (9.49%; 95% CI: 8.93%–
10.85%), including 747 males and 619 females, were
positive for CKD. The rates of hematuria, albuminuria
and reduced eGFR (<60 mL/min/1.73 m2) in subjects
with CKD were 4.20%, 5.25% and 1.89%, respectively, al-
though only 1.4% of these subjects were aware they had
CKD. The prevalence of CKD was similar in males and
females, while the rates of albuminuria and reduced
eGFR were significantly higher in males (p < 0.01 each)Table 1 Sociodemographic and clinical characteristics of the p
Characteristics Total (x± s) Males (x±
Number 14 399 8 561
Age (years) 48.97 ± 17.02 49.64 ± 16.6
BMI (kg/m2) 24.29 ± 3.12 25.58 ± 3.43
SBP (mmHg) 124.32 ± 18.56 128.78 ± 18
DBP (mmHg) 72.38 ± 11.93 85.12 ± 13.9
Scr (μmol/L) 79.10 ± 29.18 90.32 ± 20.7
UA (μmol/L) 286.28 ± 89.04 297.5 ± 90.6
FBG (mmol/L) 5.8 ± 1.61 5.85 ± 1.66
TG (mmol/L) 1.57 ± 1.16 1.62 ± 1.23
TCH (mmol/L) 4.85 ± 1.05 4.84 ± 1.00
HDL-C (mmol/L) 1.46 ± 0.42 1.43 ± 0.40
LDL-C (mmol/L) 2.78 ± 0.80 2.77 ± 0.79
Hematuria (%) 605(4.20%) 197(2.30%)
Albuminuria (%) 756(5.25%) 533(6.23%)
eGFR (mL/min/1.73 m2) 101.23 ± 36.03 102.74 ± 35
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; S
TCH, total cholesterol; HDL-C, density lipoprotein-cholesterol; LDL-C, low density lipand the rate of hematuria was significantly higher in
females (p = 0.002). Figure 1 shows the age-specific rates
of CKD, hematuria, albuminuria and reduced eGFR.
Rates of CKD, albuminuria and reduced eGFR differed
significantly by age (p < 0.01 each), with the rats of
CKD and reduced eGFR increasing with age, especially
among people aged > 60 years. In contrast, the rate of
albuminuria was highest in subjects aged 40–49 years.
Reduced eGFR was observed in 24.49% of subjects
aged > 80 years.
CKD Risk factors
To characterize the risk factors for CKD, anthropometric
measurements and biochemical indices were compared
in subjects with and without CKD. Univariate analysis
showed that age, BMI, SBP, DBP, Scr, UA, FBG, TG,
TCH, and LDL-C were significantly higher, while eGFR
was significantly lower, in subjects with than without
CKD (p < 0.05 each) (Table 2).
Independent factors for CKD, as well as for hematuria,
albuminuria and reduced eGFR, were analyzed by multi-
variate logistic regression analysis (Table 3). Factors
independently associated with CKD included older age,
female gender, smoking, high SBP and a history of diabetes
mellitus, hyperlipidemia, hypercholesterolemia, hyperuri-
cemia, and lower level of education. Older age, male gen-
der, obesity, high SBP, hyperlipidemia, and smoking were
independent risk factors for albuminuria; female gender
and high SBP were risk factors for hematuria; and older
age, female gender, and histories of cardiovascular disease,
diabetes mellitus, hyperlipidemia, hypercholesterolemia,articipants
s) Female (x± s) t/χ2 p-value
5 838 - -
5 48.13 ± 18.01 3.52 0.001
23.51 ± 3.52 31.09 0.001
.24 120.72 ± 17.39 15.23 0.000
2 75.93 ± 11.57 27.12 0.000
8 65.29 ± 14.71 50.23 0.000
0 271.31 ± 88.2 17.22 0.000
5.73 ± 1.56 4.39 0.000
1.47 ± 1.14 7.63 0.000
4.87 ± 1.07 −1.64 0.101
1.53 ± 0.54 −13.05 0.000
2.80 ± 0.81 −2.81 0.005
408(6.9%) 120.72 0.000
223(3.82%) 49.78 0.000
.30 100.85 ± 37.42 3.08 0.002
cr, serum creatinine; UA, uric acid; FBG, fasting blood glucose; TG, triglyceride;
oprotein-cholesterol; eGFR, estimated glomerular filtration rate.
Figure 1 Age-specific prevalence of indicators of chronic
kidney disease.
Xue et al. BMC Nephrology 2014, 15:205 Page 4 of 6
http://www.biomedcentral.com/1471-2369/15/205and hyperuricemia were independent risk factors for
reduced eGFR.
Discussion
This is the first surveillance of CKD patients among
subjects who visit selected hospitals in Taian City for
primary care. This cross-sectional study evaluating the
epidemiology of CKD and factors associated with it
from September to December 2012. The key findings
of this study were that 9.49% of the representative
participants in Taian City had at least one indicator of
CKD, whereas only 1.4% were aware that they had
this disease. Factors associated with CKD, includingTable 2 Univariate analysis of factors in subjects with and
without chronic kidney disease
Patients with
CKD (x± s) People withoutCKD (x± s) t p-value
Age (years) 52.27 ± 13.18 43.78 ± 12.24 14.53 0.000
BMI (kg/m2) 25.78 ± 3.62 25.19 ± 4.01 4.68 0.000
SBP (mmHg) 137.01 ± 20.37 123.16 ± 16.52 14.12 0.000
DBP (mmHg) 83.19 ± 15.22 75.23 ± 11.85 8.19 0.000
Scr (μmol/L) 87.92 ± 56.72 77.43 ± 19.75 25.92 0.000
UA (μmol/L) 328.15 ± 88.62 308.19 ± 72.18 2.71 0.023
FBG (mmol/L) 5.43 ± 2.36 5.08 ± 1.30 13.16 0.000
TG (mmol/L) 2.03 ± 1.69 1.91 ± 1.43 5.01 0.000
TCH (mmol/L) 4.98 ± 1.23 4.75 ± 0.88 5.73 0.000
HDL-C (mmol/L) 1.27 ± 0.53 1.27 ± 0.52 0.22 0.762
LDL-C (mmol/L) 3.03 ± 0.94 2.73 ± 0.93 4.12 0.000
eGFR (mL/min/1.73 m2) 90.12 ± 28.19 110.32 ± 24.72 −27.17 0.000
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure;
Scr, serum creatinine; UA, uric acid; FBG, fasting blood glucose; TG, triglyceride;
TCH, total cholesterol; HDL-C, density lipoprotein-cholesterol; LDL-C, low density
lipoprotein-cholesterol; eGFR, estimated glomerular filtration rate.diabetes mellitus, hypertension and educational level,
were identified.
Our finding, that the prevalence of CKD in Taian City
was 9.49%, was consistent with the first national survey
in China, which showed that the overall prevalence of
CKD was 10.8% [7]. However, studies in other provinces
and municipalities in China have reported higher rates of
CKD, 10.1% to 13.5% in Beijing, Zhejiang and Guangdong,
and 19.1% in Tibet [18-20,22]. Most of these regions
are economically developed. The prevalence of diabetes
mellitus has been found to increase substantially with
economic development, from 5.8% in underdeveloped
regions to 12.0% in developed regions [15]. A recent
survey on the prevalence of CKD with type 2 diabetes
(T2DM) in US adults found that eGFR was reduced or
albuminuria present in 43.5% of the population, and
that CKD was present in 61.0% of persons aged ≥ 65
years [25]. Our survey results indicated that diabetes
mellitus was the strongest risk factor for CKD (OR = 2.06),
which may explain the higher prevalence of CKD in
Beijing, Zhejiang and Guangdong. Beijing is located in the
north of China and its residents have a higher sodium
intake in their diets [26,27]. Sodium intake has been asso-
ciated with increased blood pressure [28]. Our survey indi-
cated that the second strongest risk factor for CKD was
high SBP (OR = 1.72), an indicator of hypertension and
commonly found in subjects with progressive CKD. A
retrospective study of 540 Chinese patients with CKD
found that 39.6% had hypertension [29]. Unmeasured
confounders associated with specific geographical regions
may also contribute to variations in the prevalence of
CKD. For example, hypoxia is common in populations liv-
ing at high altitude, such as in Tibet. Laboratory studies
have shown that, with the development of hyperuricemia,
exposure of rats to intermittent hypobaric hypoxia could
lead to renal microvascular and tubulointerstitial injury,
suggesting that hypoxia itself may cause low-grade renal
injury [30].
Although the prevalence of CKD in Taian was high,
only 1.4% of individuals with CKD were aware that they
had this disease. This awareness rate was much lower
than the rates reported in Thailand (1.9%) [17], India
(7.9%) [31], and Saudi Arabia (7.1%) [32], and in a na-
tional survey throughout China (12.5%) [7]. Our survey
was performed on a primary care population, with most
of these patients with CKD being asymptomatic or hav-
ing few clinical symptoms, which may help to explain
the low disease awareness. Tests to detect early stage
CKD are available, but have not yet been used widely,
and most individuals do not undergo regular urine test-
ing. Lack of healthcare resources must be considered.
The World Health Organization (WHO) has reported
that, in developing nations, government spending on
health care was only 0.4% to 4% of the gross national
Table 3 Factors independently associated with albuminuria, haematuria, reduced eGFR, and chronic kidney disease
among subjects in Taian
Albuminuria OR (95% CI) Haematuria OR (95% CI) Reduced eGFRa OR (95% CI) CKD OR (95% CI)
Age 1.11 (1.03-1.36) - 2.38 (2.13-2.63) 1.27 (1.16-1.40)
Female 0.61 (0.510.73) 3.12 (2.43-3.83) 1.70 (1.19-2.41) 1.40 (1.18-1.63)
Obesity 1.25 (1.12-1.41) - 0.82 (0.73-0.94) -
High SBP 2.23 (1.82-2.68) 1.52 (1.07-2.17) - 1.72 (1.41-2.09)
Cardiovascular disease - - 2.5 (1.29-5.03) -
Using nephrotoxic drugs - - - -
Diabetes mellitus 1.91 (1.53-2.31) - 1.77 (1.36-2.18) 2.06 (1.53-2.62)
Hyperlipidemia 1.24 (1.03-1.45) - 1.48 (1.02-2.03) 1.28 (1.05-1.63)
Hypercholesterolemia - - 1.59 (1.20-2.03) 1.18 (1.08-1.29)
Hyperuricemia - - 3.50 (2.12-4.89) 1.44 (1.09-1.86)
Smoking 1.38 (1.12-1.87) - - 1.29 (1.06-1.64)
≥ High school education - - 0.61 (0.39-0.95) 0.75 (0.65-0.87)
SBP, systolic blood pressure.
amL/min/1.73 m2.
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tries [33]. Compared with those unaware of having CKD,
participants who were aware of their condition were
more educated [34]. Our results also showed that higher
educational level may be protective in CKD patients
(OR = 0.75). Because less educated individuals have fewer
health information contacts, they often pay less atten-
tion to self-care advice and are less aware of the occur-
rence of chronic disease, which may delay treatment.
Long-term reduction of CKD morbidity and mortality
requires more attention to early detection and preven-
tion at the population level, especially in less educated
subjects [35,36].
This study used a multi-stage stratified cluster sam-
pling procedure to obtain a representative sample of the
primary care population in Taian City. All participating
staff received intensive training before starting the sur-
vey and standardized protocols were used to ensure the
quality of collected data. Additional advantages include
the high response rate and the use of the MDRD equa-
tion modified for Chinese patients. All of these factors
enhanced the credibility of the study results.
However, this study had several limitations. First, only
one blood and one urine sample were obtained from
each participant, making it difficult to determine whether
hematuria or albuminuria was transient or persistent. Sec-
ond, this study was cross-sectional and not longitudinal,
preventing determination of whether any risk factors were
the cause or result of CKD. Finally, this study was based
on a primary care population; thus, the correct sampling
weights were not used for insufficient data, thus limiting
the generalization of our results to the general population
of Taian.Conclusions
In conclusion, this is the first epidemiological survey of
CKD in a large primary care population in Taian, China.
The prevalence of CKD was found to be 9.49%, while
the rate of awareness was much lower. Age, gender, edu-
cational level, smoking, SBP and history of diabetes
mellitus, hyperlipidemia, hypercholesterolemia and hyper-
uricemia were independently associated with CKD. The
prevalence of CKD may be reduced by controlling the
increasing incidence of diabetes and hypertension in Taian.
Health education and preventive policies for the general
population are imperative. Rigorous designed studies with
longitudinal data are required to confirm our results.Abbreviations
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